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Stress Tests Fail (Caught Between
Guidelines and Gut Feeling)*
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Computed tomography coronary angiography (CTCA) has
evolved into a robust coronary imaging technique because of
improvements in temporal and spatial resolution, short scan
times, and ever lower patient radiation exposure. Although
CTCA has demonstrated excellent accuracy for excluding
obstructive coronary artery disease (CAD), its role in the
diagnostic work-up of patients with symptoms suspicious
for CAD, in relation to established noninvasive stress
(imaging) tests is still not well defined.
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Assessment of patients with chest pain in general follows
an established stepwise approach, as recommended in
American College of Cardiology/American Heart Associa-
tion and European Society of Cardiology guidelines (1,2).
The first step involves careful history taking, physical
examination, and risk factor assessment to determine the
pre-test likelihood of CAD, in an explicit manner using
established or contemporary prediction algorithms (3–5).
Further management depends on whether a patient is
classified in the low, intermediate, or high pre-test likeli-
hood category. The second step involves stress testing to
confirm myocardial ischemia as the cause of symptoms and
to identify patients who may merit medical treatment to
relieve symptoms or who may merit selective invasive
coronary angiography (ICA) and consideration for revascu-
larization to relief symptoms and improve prognosis.
Traditionally, stress testing includes exercise electrocar-
diography, stress echocardiography, or myocardial perfusion
scintigraphy. Although simple and straightforward in con-
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and the low yield of invasive angiography to detect obstruc-
tive coronary disease—27% to 49% in women and 47% to
67% in men (6,7)—illustrates the suboptimal performance
of the current diagnostic work-up. Reasons for this include
the modest correlation between stress tests results and
angiographic disease severity, at least in perception, and
that an increasing proportion of patients are referred for
invasive angiography without even an attempt at noninva-
sive evaluation (6). There is a need for improved noninva-
sive evaluation to decrease the number of normal invasive
angiograms. The excellent ability of CTCA to exclude
significant CAD could make it a more effective gatekeeper
to ICA than stress testing (8). While intuitively sensible,
there are limited data on the efficacy of CTCA as a second
test to confirm or refute the initial functional stress test with
equivocal or conflicting results.
Chinnaiyan et al. (9), in this issue of the Journal,
evaluated the predictive value of CTCA in patients with
inconclusive stress tests, which is in line with guidelines. In
addition, they evaluated CTCA in patients in whom initial
stress tests outcomes needed adjudication with CTCA
because of discordance between symptoms, pre-test likeli-
hood of CAD, and stress test, as perceived by the treating
physician. They studied 6,198 patients without known
CAD who were undergoing CTCA within 3 months after
a stress test, of a total of 22,551 CTCA patients collected
from 47 centers by the ACIC (Advanced Cardiovascular
Imaging Consortium) in Michigan. The investigators tested
the incremental value of clinical information, cardiovascular
risk (Framingham Risk Score with additional risk parame-
ter), probability of CAD, and stress testing to predict CAD
on cardiac computed tomography using C-statistics. They
found that stress testing had no incremental value to clinical
information or pre-test likelihood of CAD. In a subset of
621 patients who were referred to ICA, they demonstrated
that only CTCA had incremental value compared with
clinical information, pre-test likelihood, and stress testing to
predict 50% stenosis on ICA. They further demonstrated
that presuming that 80% (4,650 of 6,198) of the patients
with equivocal or abnormal test would be referred to ICA,
adjudication to CTCA decreased referral to 20%, indeed an
effective gatekeeper. Overall, the approach of adjudication
of conflicting stress results was successful and led to a
diagnostic yield of ICA of 57% to detect 50% stenosis,
which is an improvement over previous data, but still lower
than desirable.
There are a number of other issues that deserve further
discussion. While sometimes conflicting, at least in appear-
ance, invasive or noninvasive angiography and functional
testing provide complementary data, both of which are
important in the management of patients with suspected
CAD. Before dismissing functional testing as noncontrib-
uting in the risk assessment process, we should also ac-
knowledge that CTCA as the reference outcome has a
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positive predictive value of CTCA in this study was only
71% in comparison to that of invasive angiography.
It is also important to reiterate the acknowledged biases
in the comparison between CTCA and stress testing in the
ACIC registry (9). The population selected leaned toward
patients with conflicting or equivocal stress test results—
patients with clearly positive or negative results that con-
firmed clinical suspicion were excluded—thereby potentially
inducing a “self-fulfilling prophecy” that CTCA is indeed a
better test. That was further amplified by referral and
validation bias to ICA by demonstrating the superiority of
CTCA to predict angiographic stenosis on ICA. The choice
of a moderately severe anatomical endpoint, CTCA 50%
stenosis, which is a poor predictor of myocardial ischemia,
stacked the cards in favor of a noninvasive anatomical
modality. That a moderately stenotic lesion does not cause
objective myocardial ischemia does not imply that the
functional test result is incorrect, or that the obtained
information is meaningless for further management of that
patient. Not unlikely, results would have been different if a
70% threshold or fractional flow reserve had been selected
as a reference.
Indeed, the present study by Chinnaiyan et al. (9)
provides valuable insights into what is the current practice
use of CTCA in the management of patients with chest
pain. In the original population, 30% (9,348 of 22,551)
appear to have undergone CTCA without prior stress tests.
While this approach is not yet widely embraced, there are
indeed emerging data to suggest that cardiac CT may be a
more efficient initial test to rule out CAD (8). More
controversial is the referral to CTCA of patients with a
history of CAD (25%) and asymptomatic patients (5%).
Although these referrals appear to be deviations from
current practice guidelines (10–12), the study also teaches
us that clinical judgment, although arbitrary and not well
defined, does have value, and “gut feeling” may prompt a
second test to “correct” tests with a high suspicion of false
positive or negative outcomes, thereby avoiding a substantial
number of catheterizations. Nevertheless, we should be
aware of the potential overuse of cardiac testing, and may
want to rethink our current practice of arguably less appro-
priate first tests in patients with low pre-test probability of
CAD, inevitably leading to substantial numbers of false
positive results, which consequently necessitate a second test
to avoid a likely-to-be-negative invasive examination. The
study is interesting, revealing, stimulates our diagnostic
thinking, and should prompt a prospective well-designed
study in which the need for adjudication with a second test,
in case of diagnostic uncertainty after a initial diagnostic
test, is based on the post-test likelihood of CAD, with
pre-specified levels of diagnostic uncertainty, thereby pro-
viding more support to judicious referral to another test to
increase the diagnostic yield of ICA to detect obstructive
disease.Reprint requests and correspondence: Dr. Pim J. de Feyter,
Thoraxcenter, Erasmus Medical Center, Department of Cardiol-
ogy and Radiology, Hs207, P.O. Box 2040, Rotterdam, Zuid
Holland 3000 CA, the Netherlands. E-mail: p.j.defeyter@
erasmusmc.nl.
REFERENCES
1. Fox K, Garcia MA, Ardissino D, et al. Guidelines on the management
of stable angina pectoris: executive summary: the Task Force on the
Management of Stable Angina Pectoris of the European Society of
Cardiology. Eur Heart J 2006;27:1341–81.
2. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline
update for the management of patients with chronic stable angina—
summary article: a report of the American College of Cardiology/
American Heart Association Task Force on Practice Guidelines
(Committee on the Management of Patients With Chronic Stable
Angina). J Am Coll Cardiol 2003;41:159–68.
3. Diamond GA, Forrester JS. Analysis of probability as an aid in clinical
diagnosis of coronary artery disease. N Engl J Med 1979;300:1350–8.
4. Pryor DB, Shaw L, McCants CB, et al. Value of history and physical
in identifying patients at increased risk for coronary artery disease. Ann
Intern Med 1993;118:81–90.
5. Genders TSS, Steyerberg EW, Alkadi H, et al. A clinical prediction
rule for the diagnosis of coronary artery disease: validation, updating
and extension. Eur Heart J 2011;32:1316–30.
6. Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective
coronary angiography. N Engl J Med 2010;362:886–95.
7. Shaw L, Mieres JH, Hendel RJ, et al. Comparative effectiveness of
exercise electrocardiography with or without myocardial perfusion
single photon computed tomography in women with suspected coro-
nary artery disease. Results from the What Is the Optimal Method for
Ischemia Evaluation in Women trial. Circulation 2011;124:1239–49.
8. Weustink AC, Mollet NR, Neefjes LA, et al. Diagnostic accuracy and
clinical utility of noninvasive testing for coronary artery disease. Ann
Intern Med 2010;152:630–9.
9. Chinnaiyan KM, Raff GL, Goraya T, et al. Coronary computed
tomography angiography after stress testing: results from a multi-
center, statewide registry, ACIC (Advanced Cardiovascular Imaging
Consortium). J Am Coll Cardiol 2012;59:688–95.
10. Bluemke DA, Achenbach S, Budoff M, et al. Noninvasive coronary
artery imaging: magnetic resonance angiography and multidetector
computed tomography angiography. A scientific statement from the
American Heart Association Committee on Cardiovascular Imaging
and Intervention of the Council on Cardiovascular Radiology and
Intervention, and the Councils on Clinical Cardiology and Cardiovas-
cular Disease in the Young. Circulation 2008;118:586–606.
11. Schroeder S, Achenbach S, Bengel F, et al. Cardiac computed
tomography: indications, applications, limitations, and training re-
quirements: report of a writing group deployed by the Working Group
Nuclear Cardiology and Cardiac CT of the European Society of
Cardiology and the European Council of Nuclear Cardiology. Eur
Heart J 2008;29:531–56.
12. Taylor AJ, Cerqueira M, Hodgson J, et al. ACCF/SCCT/ACR/
AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use cri-
teria for cardiac computed tomography: a report of the American
College of Cardiology Foundation Appropriate Use Criteria Task
Force, the Society of Cardiovascular Computed Tomography, the
American College of Radiology, the American Heart Association, the
American Society of Echocardiography, the American Society of
Nuclear Cardiology, the North American Society for Cardiovascular
Imaging, the Society for Cardiovascular Angiography and Interven-
tions, and the Society for Cardiovascular Magnetic Resonance. J Am
Coll Cardiol 2010;56:1864–94.
Key Words: Advanced Cardiovascular Imaging Consortium (ACIC)
y coronary computed tomography angiography y gatekeeper y stress
tests.
